Home
>
National Drug Code (NDC)
>
Incivek
Incivek - 51167-100-01 - (telaprevir)
Drug Information of Incivek
| Product NDC: | 51167-100 |
| Proprietary Name: | Incivek |
| Non Proprietary Name: | telaprevir |
| Active Ingredient(s): | 375 mg/1 & nbsp; telaprevir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Incivek
| Product NDC: | 51167-100 |
| Labeler Name: | Vertex Pharmaceuticals Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201917 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110523 |
Package Information of Incivek
| Package NDC: | 51167-100-01 |
| Package Description: | 4 BOX in 1 CARTON (51167-100-01) > 7 BLISTER PACK in 1 BOX > 6 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of Incivek
| NDC Code | 51167-100-01 |
| Proprietary Name | Incivek |
| Package Description | 4 BOX in 1 CARTON (51167-100-01) > 7 BLISTER PACK in 1 BOX > 6 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 51167-100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | telaprevir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110523 |
| Marketing Category Name | NDA |
| Labeler Name | Vertex Pharmaceuticals Incorporated |
| Substance Name | TELAPREVIR |
| Strength Number | 375 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HCV NS3/4A Protease Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
